Greater Development of 1,2-Dimethylhydrazine-induced Colon Cancer in a Rat Model of Type 2 Diabetes Mellitus

Abstract

Several clinical cohort and case-control studies have suggested a link between diabetes and colon cancer. Otsuka Long-Evans Tokushima Fat (OLETF) rats spontaneously develop type 2 diabetes mellitus and Long-Evans Tokushima Otsuka (LETO) rats are non-diabetic. The relationship between type 2 diabetes mellitus and colon cancer was examined in these rats. The carcinogen 1, 2-dimethylhydrazine was administered subcutaneously once weekly for 10 weeks, and the animals were killed and necropsied in week 29. All OLETF rats and 80% of the LETO rats developed cancer. The number of colon cancers per rat was significantly greater in the diabetic than in the non-diabetic rats. Although the tumours tended to be larger in diabetic rats, the difference was not statistically significant. No significant differences were observed in the depth of invasion or histological type of cancer in the two groups. Type 2 diabetes mellitus may enhance the generation and growth of colon cancer.

Keywords

1,2-Dimethylhydrazine Carcinogens Colon cancer Type 2 diabetes mellitus Rat model

References

Kono

Honjo

Todoroki

Nishiwaki

Hamada

Nishikawa

: Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 1998; 9: 441–446.

Will

Galuska

Vinicor

Calle

: Another complication of diabetes mellitus? Am J Epidemiol 1998; 147: 816–825.

Manson

Liu

Hunter

Colditz

Michels

: Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542–547.

Schoen

Tangan

Kuller

Hunter

Colditz

Michels

: Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 1147–1154.

Yamada

Araki

Tamura

Sakai

Takahashi

Kashihara

: Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 1998; 27: 794–798.

Kaaks

Toniolo

Akhmedkhanov

Lukanova

Biessy

Dechaud

: Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592–1600.

Saydah

Lorita

Eberhardt

Brancati

: Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003; 157: 1092–1100.

Limburg

Anderson

Johnson

Jacobs

Jr Lazovich

Hong

: Diabetes mellitus and subsite-specific colorectal cancer risk in the Iowa Women's Health Study. Cancer Epidemiol Biomarker Prev 2005; 14: 133–137.

Wei

Pollak

Rifai

Fuchs

Hankinson

: A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarker Prev 2005; 14: 850–855.

10.

Kawano

Hirashima

Mori

Saitou

Kurosumi

Natori

: Spontaneous long-term hyperglycemic rat with diabetic complications. Diabetes 1992; 41: 1422–1428.

11.

Giovannuci

: Insulin and colon cancer. Cancer Causes Control 1995; 6: 164–179.

12.

Corpet

Jacquinet

Peiffer

Tache

: Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 1997; 27: 316–320.

13.

Tran

Medline

Bruce

: Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarker Prev 1996; 5: 1013–1015.

14.

Giovannucci

: Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J Nutr 2001; 131: 3109S–3120S.

15.

Sandhu

Dunger

Giovannucci

: Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002; 94: 972–980.